François Girardin

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


89 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 1999 |
Sous presse
 
Highly sensitive ultra-high-performance liquid chromatography coupled with tandem mass spectrometry method for the multiplex analysis of levosimendan and its metabolites OR-1855 and OR-1896 in human plasma
Bertin Stéphane, Versace François, Mercier Thomas, Murisier Amarande, Sauvain Geraldine, Haefliger David, Girardin François R., Perez Maria-Helena, Raphaël Giraud, Schneider Antoine et al. Journal of Pharmaceutical and Biomedical Analysis.
[DOI][serval:BIB_746184B29E5C]
 
Microvascular Inflammation of Kidney Allografts and Clinical Outcomes
Sablik Marta, Sannier Aurélie, Raynaud Marc, Goutaudier Valentin, Divard Gillian, Astor Brad C., Weng Patricia, Smith Jodi, Garro Rouba, Warady Bradley A. et al. New England Journal of Medicine.
[DOI][Pmid][serval:BIB_032D35160D0D]
 
Importance of Sex-Dependent Differences for Dosing Selection and Optimization of Chemotherapeutic Drugs.
Seydoux C., Briki M., Wagner A.D., Choong E., Guidi M., Carrara S., Thoma Y., Livio F., Girardin F.R., Marzolini C. et al. Chemotherapy. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_84F759610A36]
2024
 
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV
Thoueille Paul, Saldanha Susana Alves, Schaller Fabian, Choong Eva, Veuve François, Munting Aline, Cavassini Matthias, Braun Dominique, Günthard Huldrych F., Duran Ramirez Jessy J. et al., 2024/11/15. Frontiers in Pharmacology, 15. Peer-reviewed.
[DOI][serval:BIB_9DDB05C5BD5C]
Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN).
Goutaudier V., Danger R., Catar R.A., Racapé M., Philippe A., Elias M., Raynaud M., Aubert O., Bouton D., Girardin F. et al., 2024/11. Kidney international, 106 (5) pp. 943-960. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1CCC1ACCEB87]
Prevalence of actionable pharmacogenetic variants and high-risk drug prescriptions: A Swiss hospital-based cohort study.
Hodel F., De Min M.B., Thorball C.W., Redin C., Vollenweider P., Girardin F., Fellay J., 2024/09. Clinical and translational science, 17 (9) pp. e70009. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F053E42785D]
Exposures to non-therapeutic chemicals before, during and after pregnancy: data from the Swiss Teratogen Information Service (STIS).
Srikantha P., Winterfeld U., Girardin F., Panchaud A., Ochsenbein-Kölble N., Simões-Wüst A.P., 2024/07/16. Swiss medical weekly, 154 p. 3751. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1485D89DBE55]
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long-Acting Intramuscular Injection in Real-World People with HIV.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Veuve F., Munting A., Cavassini M., Braun D., Günthard H.F., Duran Ramirez J.J. et al., 2024/06. Clinical pharmacology and therapeutics, 115 (6) pp. 1450-1459. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A008171B295E]
Use of GLP1 receptor agonists in early pregnancy and reproductive safety: a multicentre, observational, prospective cohort study based on the databases of six Teratology Information Services.
Dao K., Shechtman S., Weber-Schoendorfer C., Diav-Citrin O., Murad R.H., Berlin M., Hazan A., Richardson J.L., Eleftheriou G., Rousson V. et al., 2024/04/24. BMJ open, 14 (4) pp. e083550. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AC208C4ACC61]
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update.
Briki M., Murisier A., Guidi M., Seydoux C., Buclin T., Marzolini C., Girardin F.R., Thoma Y., Carrara S., Choong E. et al., 2024/04/01. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1236 p. 124039. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CC804B352E24]
Population pharmacokinetic analysis of doravirine in real-world people with HIV.
Thoueille P., Delarive L., Cavassini M., Buclin T., Decosterd L.A., Marzolini C., Girardin F.R., Guidi M., Swiss HIV Cohort Study, 2024/04. British journal of clinical pharmacology, 90 (4) pp. 1058-1065. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0E37EFB8FE58]
Improving Data Collection in Pregnancy Safety Studies: Towards Standardisation of Data Elements in Pregnancy Reports from Public and Private Partners, A Contribution from the ConcePTION Project.
Favre G., Richardson J.L., Moore A., Geissbühler Y., Jehl V., Oliver A., Shechtman S., Diav-Citrin O., Berlin M., De Haan T. et al., 2024/03. Drug safety, 47 (3) pp. 227-236. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C5487C3C03C0]
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
Thoueille P., Cavassini M., Guidi M., Buclin T., Girardin F.R., Decosterd L.A., Marzolini C., 2024/02. Open forum infectious diseases, 11 (2) pp. ofae023. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E70DD8E56C37]
 
Pharmacovigilance. Sevrage et effet rebond: pas seulement avec les psychotropes [Pharmacovigilance. Withdrawal and rebound effects: not just with psychotropic drugs]
Marouf R., Chtioui H., Girardin F.R., Buclin T., Diezi L., 2024/01/17. Revue medicale suisse, 20 (856-7) pp. 96-101. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_22BF36045EE8]
Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy.
Cannilla H., Messe M., Girardin F., Borruat F.X., Bally J.F., 2024. Tremor and other hyperkinetic movements, 14 p. 23. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44877DB662EE]
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P., Saldanha S.A., Schaller F., Choong E., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B. et al., 2024/01. The Lancet regional health. Europe, 36 p. 100793. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_EE4919775F0F]
2023
Antidepressants and the risk of bleeding in the era of anti-amyloid drugs.
Pozuelo Moyano B., Salvioni P., Zullo L., Rouaud O., von Gunten A., Girardin F.R., Allali G., 2023/12. Alzheimer's & dementia, 19 (12) pp. 5847-5848. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B8B8E3A8AB5C]
 
Therapeutic drug monitoring of TB drugs
Choong Eva, Marzolini Catia, Girardin François, Decosterd Laurent, Köhler Niklas, 2023/12. dans Translational TB-Forum, Inselspital Bern, December 11, 2023. Peer-reviewed.
[serval:BIB_71F805AD727A]
Pregnancy outcomes after GLP-1 agonist exposure in early pregnancy
Winterfeld Ursula, Dao Kim, Haefliger David, Diezi Léonore, Girardin François, 2023/11/23. Swissmedic Vigilance News. Peer-reviewed.
[URN][serval:BIB_9BF96D812CDD]
Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
Tachet J., Versace F., Mercier T., Buclin T., Decosterd L.A., Choong E., Girardin F.R., 2023/11/15. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1230 p. 123917. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_670CB2162D89]
Cost-effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Switzerland
Goossens Nicolas, Garay Osvaldo Ulises, Wolf Cyrill, Ambühl Louisa Elena, Kugler Vanessa, Girardin François, 2023/09/11., Annual Meeting of the Swiss Society of Gastroenterology (SGG-SSG), the Swiss Society of Visceral Surgery (SGVC-SSCV), the Swiss Association for the Study of the Liver (SASL) and the Swiss Society of Endoscopy Nurses and Associates (SVEP-ASPE), 14-15 September pp. 6S dans Swiss Medical Weekly.
[URN][WoS][serval:BIB_3C9E2B550ECB]
Supplementum 272: Abstracts of the Annual meeting of the Swiss Society of Gastroenterology, the Swiss Society of Visceral Surgery, the Swiss Association for the Study of the Liver and the Swiss Society of Endoscopy Nurses and Associates
Juillerat Pascal, Tachet Jérémie, Mercier Thomas, Versace François, Guidi Monia, Buclin Thierry, Decosterd Laurent, Choong Eva, Girardin François, 2023/09/11., Annual meeting of the Swiss Society of Gastroenterology , the Swiss Society of Visceral Surgery, the Swiss Association for the Study of the Liver, the Swiss Society of Endoscopy Nurses and Associates pp. s3511 dans Swiss Medical Weekly, François. Peer-reviewed, SMW Supporting Association.
[URN][DOI][Pmid][serval:BIB_478A7CAB2010]
 
A Highly Sensitive HPLC-MS/MS MethodFor Multiplex Analysis Of Janus KinaseInhibitors In Plasma
Tachet J., Mercier T., André P., Guidi M., Buclin T., Decosterd L., Choong E., Girardin F., 2023/07. dans 19th World Congress of Basic and Clinical Pharmacology (WCP), Glasgow, July 2023.
[serval:BIB_D39D174AB865]
Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines.
Ekobena P., Rothuizen L.E., Bedussi F., Guilcher P., Meylan S., Ceschi A., Girardin F., Dao K., 2023/06. International journal of audiology, 62 (6) pp. 587-591. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2ACA564D1A62]
Ibrutinib and venetoclax associated with progressive multifocal leukoencephalopathy
Haefliger David, Girardin François, 2023/05/30. Swissmedic Vigilance News. Peer-reviewed.
[URN][serval:BIB_7D819B42B9D4]
JAK inhibitors: need for dosage individualisation?
Tachet Jérémie, Girardin François, 2023/05/30. Swissmedic Vigilance News . Peer-reviewed.
[URN][serval:BIB_E5B14375BECF]
 
A highly sensitive HPLC-MS/MS method for multiplex analysis of janus kinase inhibitors in plasma
Tachet Jérémie, André Pascal, Guidi Monia, Buclin Thierry, Decosterd Laurent Arthur, Choong Eva, Girardin François, 2023/05/10. dans Congrès SSMIG 2023 - 10 au 12 mai 2023.
[serval:BIB_449F9C0F20F5]
Editorial: Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment.
Girardin F.R., Cohen K., Schwenkglenks M., Durand-Zaleski I., 2023. Frontiers in pharmacology, 14 p. 1210002. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1C74847FFDC9]
Immunosuppressant drugs and quality-of-life outcomes in kidney transplant recipients: An international cohort study (EU-TRAIN).
Girardin F.R., Nicolet A., Bestard O., Lefaucheur C., Budde K., Halleck F., Brouard S., Giral M., Gourraud P.A., Horcholle B. et al., 2023. Frontiers in pharmacology, 14 p. 1040584. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E5F96D1F8644]
2022
Inhibiteurs des Janus kinases : nouvelles perspectives pour la médecine de précision ? [Janus kinase inhibitors : new perspectives for precision medicine ?]
Tachet J., Dumusc A., Conrad C., Grandoni F., Chalandon Y., Ribi C., Buclin T., Girardin F., 2022/10/19. Revue medicale suisse, 18 (800) pp. 1979-1983. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0D12F79D0C49]
 
Evaluating the risk of drug-drug interactions with pharmacokinetic boosters: the case of ritonavir-enhanced nirmatrelvir to prevent severe COVID-19.
Girardin F., Manuel O., Marzolini C., Buclin T., 2022/08. Clinical microbiology and infection, 28 (8) pp. 1044-1046. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_30CD844F1841]
Multifocal lymphadenopathies with polyclonal reactions primed after EBV infection in a mRNA-1273 vaccine recipient.
Girardin F.R., Tzankov A., Pantaleo G., Livio F., Greub G., 2022/05/23. Swiss medical weekly, 152 pp. w30188. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_378A2D414165]
Scaling-up hepatitis C screening and treatment in Swiss outpatient psychiatric settings: A cost-effectiveness analysis.
Girardin F., Tuch A., Eddowes L., Preisig M., Negro F., 2022/05. JHEP reports, 4 (5) p. 100464. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E42C64DE613C]
Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.
Follonier C., Tessitore E., Handgraaf S., Carballo D., Achard M., Pechère-Bertschi A., Mach F., Herrmann F.R., Girardin F.R., 2022. PloS one, 17 (11) pp. e0277653. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_415F818E90D6]
Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis.
Ninomiya K., Saito T., Ikeda M., Iwata N., Girardin F.R., 2022. Frontiers in pharmacology, 13 p. 1016669. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0E1B390736D5]
2021
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode.
Tessitore E., Handgraaf S., Poncet A., Achard M., Höfer S., Carballo S., Marti C., Follonier C., Girardin F., Mach F. et al., 2021/12/06. Swiss medical weekly, 151 pp. w30093. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_407CF11BBB60]
Hepatitis C prevalences in the psychiatric setting: Cost-effectiveness of scaling-up screening and direct-acting antiviral therapy.
Girardin F., Painter C., Hearmon N., Eddowes L., Kaiser S., Negro F., Vernaz N., 2021/06. JHEP reports, 3 (3) p. 100279. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8EF19F8ED090]
Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease.
Tessitore E., Carballo D., Poncet A., Perrin N., Follonier C., Assouline B., Carballo S., Girardin F., Mach F., 2021/04. Open heart, 8 (1) pp. e001526. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4306C0375B1D]
2020
Pharmacogénomique et aide à la prescription médicamenteuse [Pharmacogenomics : a toolbox to improve drug prescription]
Jaccard E., Redin C., Girardin F., Waeber G., Fellay J., Vollenweider P., 2020/11/25. Revue medicale suisse, 16 (716) pp. 2259-2263. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_227B3780CEBD]
Bevacizumab Induced Thrombotic Microangiopathy in a 71-Year Old Glioblastoma Patient
Chevallier Mathieu, Girardin Francois, Mirlesse Nicolas, Koessler Thibaud, 2020. Clinics of Oncology, 03 (01).
[URN][DOI][serval:BIB_C9F7E3968F6A]
 
Direct-acting antiviral interactions with opioids, alcohol or illicit drugs of abuse in HCV-infected patients
Ing Lorenzini K., Girardin F., 2020/01. Liver Int, 40 (1) pp. 32-44.
[DOI][Pmid][serval:BIB_05EDEEAF88CB]
 
Emerging Concepts and Applied Machine Learning Research in Patients with Drug-Induced Repolarization Disorders
Bjelogrlic M., Robert A., Miribel A., Namdar M., Gencer B., Lovis C., Girardin F., 2020. Stud Health Technol Inform, 270 pp. 198-202.
[DOI][Pmid][serval:BIB_09F22A044FFC]
2019
Modelling the Impact and Cost-effectiveness of Extended Hepatitis C Virus Screening and Treatment with Direct-acting Antivirals in a Swiss Custodial Setting.
Girardin F., Hearmon N., Castro E., Negro F., Eddowes L., Gétaz L., Wolff H., 2019/11/13. Clinical infectious diseases, 69 (11) pp. 1980-1986. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2AD52FAAD863]
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine
Girardin F. R., Poncet A., Perrier A., Vernaz N., Pletscher M., Samer C., Lieberman J. A., Villard J., 2019/04. Pharmacogenomics J, 19 (2) pp. 211-218.
[DOI][Pmid][serval:BIB_4D7A54B3F5D9]
 
Sceening all people for HCV in detention centres cost effective
Girardin François, 2019/02/23. dans PharmacoEconomics & Oucomes news, Springer.
[serval:BIB_729374633225]
 
Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost-effectiveness analysis.
Girardin F., Hearmon N., Negro F., Eddowes L., Bruggmann P., Castro E., 2019/02. Journal of viral hepatitis, 26 (2) pp. 236-245. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_46B30BC75321]
2018
 
Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison
Chacowry Pala K., Baggio S., Tran N. T., Girardin F., Wolff H., Getaz L., 2018. BMC Infect Dis, 18 (1) p. 539.
[DOI][Pmid][serval:BIB_8B8779CFC77D]
Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America
Da Silva Santos L., Wolff H., Chappuis F., Albajar-Vinas P., Vitoria M., Tran N. T., Baggio S., Togni G., Vuilleumier N., Girardin F. et al., 2018. J Trop Med, 2018 p. 7218534.
[DOI][Pmid][serval:BIB_23F65EEB3740]
2017
 
Privat Docent thesis - Health technology assessment: a framework for economic evaluations in policy guidance and medical management
Hurst Samia (eds.), 2017..
[DOI][serval:BIB_760294563AFA]
2016
 
Early specialized care after a first unprovoked epileptic seizure
Fisch L., Lascano A. M., Vernaz Hegi N., Girardin F., Kapina V., Heydrich L., Rutschmann O., Sarasin F., Vargas M. I., Picard F. et al., 2016/12. J Neurol, 263 (12) pp. 2386-2394.
[DOI][Pmid][serval:BIB_9BA2FCFE1AC8]
 
Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease.
Pletscher M., Walker S., Moschetti K., Pinget C., Wasserfallen J.B., Greenwood J.P., Schwitter J., Girardin F.R., 2016/07/01. European heart journal. Quality of care & clinical outcomes, 2 (3) pp. 201-207. Peer-reviewed.
[DOI][Pmid][serval:BIB_2D2DC29184A2]
 
Drug Pricing Evolution in Hepatitis C
Vernaz N., Girardin F., Goossens N., Brugger U., Riguzzi M., Perrier A., Negro F., 2016. PLoS One, 11 (6) pp. e0157098.
[DOI][Pmid][serval:BIB_8692970EA3F9]
 
Early Discharge in Low-Risk Patients Hospitalized for Acute Coronary Syndromes: Feasibility, Safety and Reasons for Prolonged Length of Stay
Laurencet M. E., Girardin F., Rigamonti F., Bevand A., Meyer P., Carballo D., Roffi M., Noble S., Mach F., Gencer B., 2016. PLoS One, 11 (8) pp. e0161493.
[DOI][Pmid][serval:BIB_F1EC4B6E1388]
 
Health utility indexes in patients with acute coronary syndromes.
Gencer B., Rodondi N., Auer R., Nanchen D., Räber L., Klingenberg R., Pletscher M., Jüni P., Windecker S., Matter C.M. et al., 2016. Open Heart, 3 (1) pp. e000419. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_ACE092D8F42E]
2015
Repenser la politique de remboursement des agents antiviraux directs contre l'hépatite C chronique [Rethinking the reimbursement policy of direct acting antivirals against chronic hepatitis C]
Girardin F., Goossens N., Vernaz N., Negro F., 2015/09/02. Revue medicale suisse, 11 (484) pp. 1610-1612,1614-1616. Peer-reviewed.
[Pmid][serval:BIB_91F6062F322D]
 
Coronary artery disease is associated with persistent lower quality of life in women.
Gencer B., Girardin F., 2015. Open heart, 2 (1) pp. e000305. Peer-reviewed.
[DOI][Pmid][serval:BIB_364AE8736A40]
 
Electrocardiographic Screening for Prolonged QT Interval to Reduce Sudden Cardiac Death in Psychiatric Patients: A Cost-Effectiveness Analysis
Poncet A., Gencer B., Blondon M., Gex-Fabry M., Combescure C., Shah D., Schwartz P. J., Besson M., Girardin F. R., 2015. PLoS One, 10 (6) pp. e0127213.
[DOI][Pmid][serval:BIB_FD170FC7A67E]
 
Rethinking pricing policy of direct antiviral agents to cure chronic hepatitis C infection at a population-level
Girardin François, 2015. Hepatology.
[WoS][serval:BIB_C2C304D3888A]
2014
 
Monitoring white blood cell count in adult patients with schizophrenia who are taking clozapine: a cost-effectiveness analysis
Girardin F. R., Poncet A., Blondon M., Rollason V., Vernaz N., Chalandon Y., Dayer P., Combescure C., 2014/06. Lancet Psychiatry, 1 (1) pp. 55-62.
[DOI][Pmid][serval:BIB_86DD7091BFC7]
 
Efficiency of the blood mandatory monitoring to detect clozapine neutropenia and monitoring of ECG in psychiatry
Girardin François, 2014. European Psychiatry.
[DOI][WoS][serval:BIB_827FA1940029]
2013
 
Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study
Girardin F. R., Gex-Fabry M., Berney P., Shah D., Gaspoz J. M., Dayer P., 2013/12. Am J Psychiatry, 170 (12) pp. 1468-76.
[DOI][Pmid][serval:BIB_C9EE47E75D88]
 
Partie 5: Individualisation du traitement
Girardin François, Schulz Pierre, 2013/12. dans Traitements biologiques en psychiatrie, de Boeck.
[serval:BIB_11C99303C1B1]
 
Pharmacotherapie Notarzt-Leitfaden
Girardin François, 2013/08. dans Schweizerischer Notarzt-Leitfaden, 8th edition 2013, EMH.
[serval:BIB_0A75AD7C4F1C]
 
Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study
Walker S., Girardin F., McKenna C., Ball S. G., Nixon J., Plein S., Greenwood J. P., Sculpher M., 2013/06. Heart, 99 (12) pp. 873-81.
[DOI][Pmid][serval:BIB_E90245E61121]
 
Enseignement de recommandations pour la pratique: la prescription médicale au cabinet [Teaching students guidelines: prescription in the practice setting]
Sommer J., Janjic D., Rieder A., Girardin F., 2013/05/15. Revue medicale suisse, 9 (386) pp. 1047-1050, 1052. Peer-reviewed.
[Pmid][serval:BIB_93C63663F113]
Emerging Concepts and Designing Effectiveness Research in the Process of Care of Patients Hospitalized with an Uncomplicated Acute Coronary Syndrome
Girardin François, 2013. Journal of Clinical Trials, 03 (02). Peer-reviewed.
[DOI][serval:BIB_C352880384CC]
Patented drug extension strategies on healthcare spending: a cost-evaluation analysis
Vernaz N., Haller G., Girardin F., Huttner B., Combescure C., Dayer P., Muscionico D., Salomon J. L., Bonnabry P., 2013. PLoS Med, 10 (6) pp. e1001460.
[DOI][Pmid][serval:BIB_7429984AA1A4]
2012
 
Chapitre 22: neurotransmission classique
Girardin François, Schulz Pierre, 2012/11. dans Psychiatrie et neurosciences (Ed. de Boeck), de Boeck.
[serval:BIB_D2B4566DFC0E]
 
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection.
Girardin F., Daali Y., Gex-Fabry M., Rebsamen M., Roux-Lombard P., Cerny A., Bihl F., Binek J., Moradpour D., Negro F. et al., 2012/08. Journal of viral hepatitis, 19 (8) pp. 568-573. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E5D4FC978C7C]
 
Pseudo-innovations: une stratégie payante d’extension des brevets?
Vernaz Nathalie, Haller Guy, Huttner Benedict, Dayer Pierre, Girardin François, Bonnabry Pascal, Muscinico Daniel, Salomon Jean-Luc, 2012/03/01. Le Pharmacien Hospitalier et Clinicien.
[serval:BIB_6CD80B15531D]
 
PATENTED DRUG EXTENSION STRATEGIES ON HEALTH CARE SPENDING: A COST-EVALUATION ANALYSIS
Girardin François, 2012. Value in Health.
[WoS][serval:BIB_98A2AF2CCE52]
2011
 
LIVER KIDNEY MICROSOMES TYPE 1 ANTIBODIES ARE ASSOCIATED WITH A SIX-FOLD REDUCTION OF THE CYP2D6 ACTIVITY IN PATIENTS WITH CHRONIC HEPATITIS C.
Girardin François, Daali Youssef, Gex-Fabry Marianne, Roux-Lombard Pascale (eds.), 2011/06/10..
[serval:BIB_A99DB06D1DCE]
 
Liver Kidney Microsomes Type 1 Antibodies are Associated with a Six-Fold Reduction of the Cyp2d6 Activity in Patients with Chron.
Girardin François, Daali Y., Gex-Fabry M., Rebsamen M., Roux-Lombard P., Cerny A., Bin J., 2011. p. 66 dans Basic & Clinical Pharmacology & Toxicology.
[WoS][serval:BIB_424283A3802F]
2009
 
An early report on the role of nitrates in erectile dysfunction
Girardin F., Berney P., Schulz P., 2009/01. Am J Psychiatry, 166 (1) p. 115.
[DOI][Pmid][serval:BIB_BBF6D0F8432E]
2008
 
PHP55 Chiralty and Hospital Formulary: a Second Life for a Blockbuster.
Vernaz-Hegi N, Girardin F, Muscionico D, Salomon JL, Bonnabry P, 2008/11. Value in Health, 11 (6) pp. A379.
[DOI][WoS][serval:BIB_C46C892692F2]
2007
Surveillance de l'intervalle QT chez le patient psychiatrique [Psychiatric patients and QT interval monitoring]
Girardin F., Gaspoz J.M., 2007/04/11. Revue medicale suisse, 3 (106) pp. 945-948. Peer-reviewed.
[Pmid][serval:BIB_22BD49CF5772]
 
Cardiac adverse reactions associated with psychotropic drugs
Girardin François, 2007/03. Dialogues Clin Neurosci.
[serval:BIB_5177BE2963B3]
 
Prescribing pattern of citalopram and escitalopram in the canton of Geneva: A potential for major savings
Girardin François, 2007. Value in Health.
[DOI][WoS][serval:BIB_70A9913861EA]
2006
 
Salmonella serovar Give: an unusual pathogen causing splenic abscess
Girardin F., Mezger N., Hachler H., Bovier P. A., 2006/04. Eur J Clin Microbiol Infect Dis, 25 (4) pp. 272-4.
[DOI][Pmid][serval:BIB_2122C14C8BDB]
 
Membrane transporter proteins: a challenge for CNS drug development
Girardin F., 2006. Dialogues Clin Neurosci, 8 (3) pp. 311-21.
[Pmid][serval:BIB_1F4F60E254EB]
2005
Traitement de l'hypertension artérielle et interactions médicamenteuses [Antihypertensive therapy and drug-drug interactions]
Girardin F., Pechère-Bertschi A., 2005/09/14. Revue medicale suisse, 1 (32) pp. 2099-2100,2102-2104. Peer-reviewed.
[Pmid][serval:BIB_8C7F0B579BB6]
Sélection d'un medicament dans une classe thérapeutique donnée: l'exemple des "inhibiteurs de l'HMG-CoA reductase" [The selection of a drug in a defined therapeutic class: the case of the HMG-CoA reductase inhibitors]
Girardin F., Desmeules J., Dayer P., 2005/04/06. Revue medicale suisse, 1 (14) pp. 949-953. Peer-reviewed.
[Pmid][serval:BIB_D5ED7E729C15]
2004
 
Inhibiteurs de l’HMGCo-A reductase : un choix fondé sur des faits
GIRARDIN FRANCOIS, 2004/02/02. PHARMA-FLASH.
[serval:BIB_2A2BFC0EA474]
2003
 
Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.
Girardin F., Rentsch K.M., Schwab M.A., Maggiorini M., Pauli-Magnus C., Kullak-Ublick G.A., Meier P.J., Fattinger K., 2003/10. Clinical pharmacology and therapeutics, 74 (4) pp. 341-352. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_950E27040DFD]
 
Rofecoxib interaction with oral anticoagulant acenocoumarol
Girardin F., Siegenthaler M., De Moerloose P., Desmeules J., 2003/09. Eur J Clin Pharmacol, 59 (5-6) pp. 489-90.
[DOI][Pmid][serval:BIB_816F25FAC5F7]
 
Utilité de la gabapentine dans les douleurs neurogènes
Girardin F., Desmeules JA, Piguet V., Dayer P., 2003/06/25. Médecine et hygiène, 61 (2443) pp. 1352-1357.
[serval:BIB_9ED8F78F2BCA]
 
Raynaud's phenomenon induced by drugs acting on neurotransmission: two cases under reboxetine and one under tegaserod
Bertoli R., Girardin F., Russmann S., Lauterburg B. H., 2003/02. Eur J Clin Pharmacol, 58 (10) p. 717.
[DOI][Pmid][serval:BIB_653A98A45D50]
2002
 
Médicaments veinotropes ou veinotoniques: un traitement d’appoint décevant, au profil de sécurité douteux
Girardin François, 2002/12. Pharma-Flash.
[serval:BIB_C26EF9BA6323]
1999
 
Relationship between corneal temperature and finger temperature
Girardin F., Orgul S., Erb C., Flammer J., 1999/02. Arch Ophthalmol, 117 (2) pp. 166-9.
[DOI][Pmid][serval:BIB_C8CBF33BC5B8]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University